Antisense oligonucleotide inhibition of cholesteryl ester transfer protein enhances RCT in hyperlipidemic, CETP transgenic, LDLr(−/−) mice

Due to their ability to promote positive effects across all of the lipoprotein classes, cholesteryl ester transfer protein (CETP) inhibitors are currently being developed as therapeutic agents for cardiovascular disease. In these studies, we compared an antisense oligonucleotide (ASO) inhibitor of C...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Thomas A., Graham, Mark J., Lee, Richard G., Mullick, Adam E., Fu, Wuxia, Norris, Dan, Crooke, Rosanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2013
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770078/
https://www.ncbi.nlm.nih.gov/pubmed/23801661
http://dx.doi.org/10.1194/jlr.M036509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770078/
https://www.ncbi.nlm.nih.gov/pubmed/23801661
http://dx.doi.org/10.1194/jlr.M036509

Ejemplares similares